PKI-166
PKI-166 is a potent, selective and orally bioavailable EGFR tyrosine kinase inhibitor, with an IC50 of 0.7 nM[1].
Product Specifications
CAS Number
187724-61-4
UNSPSC
12352005
Hazard Statement
H301
Target
EGFR
Type
Reference compound
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pki-166.html
Purity
98.92
Solubility
DMSO : ≥ 125 mg/mL
Smiles
OC1=CC=C(C2=CC3=C(N=CN=C3N2)N[C@@H](C4=CC=CC=C4)C)C=C1
Molecular Formula
C20H18N4O
Molecular Weight
330.38
Precautions
H301
References & Citations
[1]Bruns CJ, et al. Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma. Cancer Res. 2000 Jun 1;60 (11) :2926-35.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TP306859M 100 µg
Kisspeptin (KISS1) (NM_002256) Human Recombinant Protein
Sign In for Pricing
View Details 
LC401426 20 µg
ERAB (HSD17B10) (NM_004493) Human Over-expression Lysate
Sign In for Pricing
View Details 